Bristol Myers Squibb Explores the CCR8 Pathway to Advance Cancer Immunotherapy

Coverage, in order

1. 3d ago
   
   first OncoDaily obscure

   Bristol Myers Squibb Explores the CCR8 Pathway to Advance Cancer Immunotherapy

   Bristol Myers Squibb shared on LinkedIn: “Our researchers are investigating the CCR8 immune pathway as part of our work to advance innovative immunotherapy approaches for solid tumors. By studying how

2. 8h ago
   
   OncoDaily obscure

   Addressing Gaps in Lung Cancer Screening and Biomarker Testing – Bristol Myers Squibb

   Bristol Myers Squibb shared on LinkedIn: “Our work in thoracic oncology extends beyond advancing innovative science to helping ensure progress reaches patients. Lung cancer remains the leading cause of cancer

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.